Vivani Medical Inc.
VANI | NASDAQ
$1.29
+$0.05 (+4.03%)
Sep 22, 2026, 12:41 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 424K | n/a | 357K | n/a | n/a | n/a |
Gross Profit | -424K | n/a | -357K | n/a | n/a | n/a |
Operating Income | -27.56M | -24.68M | -26.97M | -21.24M | -13.32M | -9.24M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 16K |
Pretax Income | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M | -9.28M |
Net Income | -26.61M | -23.49M | -25.65M | -13.89M | -12.77M | -9.28M |
Selling & General & Admin | 9.43M | 8.93M | 10M | 5.37M | 2.32M | 2.38M |
Research & Development | 18.13M | 15.75M | 16.97M | 14.17M | 11M | 6.87M |
Other Expenses | -424K | n/a | -357K | 1.7M | n/a | n/a |
Operating Expenses | 27.13M | 24.68M | 26.61M | 21.24M | 13.32M | 9.24M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 27.56M | 24.68M | 26.97M | 21.24M | 13.32M | 9.24M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 62.39M | 54.98M | 50.85M | 38.24M | 36.25M | 28.11M |
Shares Outstanding (Diluted) | 62.39M | 54.98M | 50.85M | 38.24M | 36.25M | 28.11M |
EPS (Basic) | -0.43 | -0.43 | -0.50 | -0.17 | -0.33 | -0.33 |
EPS (Diluted) | -0.43 | -0.43 | -0.50 | -0.17 | -0.33 | -0.33 |
EBITDA | -26.19M | -23.09M | -25.3M | -19.16M | -12.43M | -8.89M |
EBIT | -26.61M | -23.49M | -25.65M | -19.54M | -12.77M | -9.24M |
Depreciation & Amortization | 424K | 400K | 357K | 381K | 345K | 354K |
Add to Watchlist
Select watchlists to add or remove VANI